Characteristic | Total (n = 48) | Brain atrophy group (n = 42) | No brain atrophy group (n = 6) | p |
---|---|---|---|---|
Demographics | ||||
Age, median (IQR), years | 73 (63–80) | 73 (63–79) | 79 (68–84) | 0.26 |
Male, n (%) | 31 (64.6) | 28 (66.7) | 3 (50.0) | 0.43 |
Medical history | ||||
Hypertension, n (%) | 16 (33.3) | 13 (31.0) | 3 (50.0) | 0.36 |
Diabetes mellitus, n (%) | 14 (29.2) | 13 (31.0) | 1 (16.7) | 0.48 |
Atrial fibrillation, n (%) | 10 (20.8) | 9 (21.4) | 1 (16.7) | 0.79 |
Clinical score | ||||
GCS score, median (IQR) | 12 (8–14) | 13 (9–14) | 10 (3–13) | 0.18 |
SOFA score, median (IQR) | 13 (11–15) | 14 (11–15) | 11 (9–15) | 0.29 |
APACHE II score, median (IQR) | 27 (21–31) | 27 (24–31) | 28 (16–31) | 0.63 |
JAAM DIC score, median (IQR) | 6 (4–7) | 6 (4–7) | 5 (3–6) | 0.26 |
Treatment | ||||
Mechanical ventilation, n (%) | 44 (91.7) | 40 (95.2) | 4 (66.7) | 0.02 |
Vasopressors, n (%) | 38 (79.2) | 35 (83.3) | 3 (50.0) | 0.06 |
Heparin, n (%) | 5 (10.4) | 5 (11.9) | 0 (0.0) | 0.38 |
Antithrombin, n (%) | 15 (31.3) | 13 (31.0) | 2 (33.3) | 0.91 |
rhTM, n (%) | 13 (27.1) | 12 (28.6) | 1 (16.7) | 0.54 |
CRRT, n (%) | 37 (77.1) | 34 (81.0) | 3 (50.0) | 0.10 |
Surgery, n (%) | 12 (25.0) | 12 (28.6) | 0 (0.0) | 0.14 |